Atlas Trials

Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer

Clinical trial NCT02546986 · TERMINATED

Trial details

NCT number
NCT02546986
Sponsor
Celgene
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2015-10-09
Primary completion
2017-04-13
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.